Literature DB >> 20147151

Construction and characterization of adenovirus vectors.

P Joel Ross, Robin J Parks.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20147151     DOI： 10.1101/pdb.prot5011

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN： 1559-6095


× No keyword cloud information.
  11 in total

1.  Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.

Authors:  Kathy L Poulin; Emily R McFall; Grace Chan; Natacha B Provost; Carin Christou; Adam C Smith; Robin J Parks
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

3.  mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells.

Authors:  Walaa Eid; Kristin Dauner; Kevin C Courtney; AnneMarie Gagnon; Robin J Parks; Alexander Sorisky; Xiaohui Zha
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

4.  Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.

Authors:  Bratati Saha; Robin J Parks
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

5.  Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Diaz-San Segundo; Elizabeth Ramirez-Medina; Luis L Rodríguez; Teresa de Los Santos
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer.

Authors:  Carmen M Wong; Kathy L Poulin; Grace Tong; Carin Christou; Michael A Kennedy; Theresa Falls; John C Bell; Robin J Parks
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

7.  Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.

Authors:  C M Wong; L A Nash; J Del Papa; K L Poulin; T Falls; J C Bell; R J Parks
Journal:  Cancer Gene Ther       Date:  2016-10-14       Impact factor: 5.987

8.  Survival Motor Neuron Protein is Released from Cells in Exosomes: A Potential Biomarker for Spinal Muscular Atrophy.

Authors:  Leslie A Nash; Emily R McFall; Amanda M Perozzo; Maddison Turner; Kathy L Poulin; Yves De Repentigny; Joseph K Burns; Hugh J McMillan; Jodi Warman Chardon; Dylan Burger; Rashmi Kothary; Robin J Parks
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

9.  An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In Vivo.

Authors:  Josh Del Papa; Julia Petryk; John C Bell; Robin J Parks
Journal:  Mol Ther Oncolytics       Date:  2019-05-15       Impact factor: 7.200

10.  Loss of Atrx sensitizes cells to DNA damaging agents through p53-mediated death pathways.

Authors:  Damiano Conte; Michael Huh; Emma Goodall; Marilyne Delorme; Robin J Parks; David J Picketts
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.